Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Total Assets history
Currency unavailable · from the balance sheet
No Total Assets data reported for this period type.
Total Assets vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $497.6M USD | +64.7% | +153.1% |
| Mar 2026 | $433.53M USD | -31.4% | -8.3% | |
| Mar 2026 | $418.79M USD | +275.4% | +130.0% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $393.48M USD | +1944.3% | +144.2% |
| Mar 2026 | $275.27M USD | -14.1% | +4.3% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $261.35M USD | +31.8% | +76.1% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $153.88M USD | -40.1% | -23.5% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — |
| Peer median (excluding SPTX) | — | +31.8% | +76.1% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.